News

Filter

Current filters:

USAAllergan

1 to 9 of 18 results

Allergan agrees to $66 billion acquisition by Actavis

Allergan agrees to $66 billion acquisition by Actavis

17-11-2014

Confirming what were becoming ever stronger rumors over the weekend, Ireland-headquartered Actavis this…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSAValeant Pharmaceuticals International

Pershing Square chief urges Allergan not to favor Actavis over Valeant in negotiations

Pershing Square chief urges Allergan not to favor Actavis over Valeant in negotiations

10-11-2014

The chief executive of the capital management company assisting Valeant Pharmaceuticals in its attempts…

ActavisAllerganBusiness FinanceBusiness FinanceCanadaPershing Square Capital ManagementPharmaceuticalUSAValeant

Allergan is reportedly in takeover talks with Actavis

Allergan is reportedly in takeover talks with Actavis

07-11-2014

Botox maker Allergan is reportedly in merger talks with Ireland-headquartered generics major Actavis,…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSA

Allergan posts strong results which provoke reaction from potential suitor Valeant

Allergan posts strong results which provoke reaction from potential suitor Valeant

27-10-2014

Botox maker Allergan has reported strong quarterly results amid an ongoing buyout dispute with Quebecois…

AllerganBotoxBusiness FinancePharmaceuticalUSAValeant

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

15-09-2014

Hostile takeover target Allergan has said that value is what “really matters” in response to Pershing…

AllerganCanadaFinancialLegalPharmaceuticalUSAValeant Pharmaceuticals International

Allergan names Jim Hindman chief financial officer

Allergan names Jim Hindman chief financial officer

19-08-2014

Allergy specialist Allergan has appointed Jim Hindman as chief financial officer, effective immediately,…

AllerganBoardroomBusiness FinanceBusiness FinanceChief financial officerJim HindmanPharmaceuticalUSA

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

1 to 9 of 18 results

COMPANY SPOTLIGHT

Menarini

Back to top